This is Not a Test: RMAT Designation Goes Live

By: Peter Marks, M.D., Ph.D. The field of regenerative medicine encompasses a wide scope of innovative products including cell therapies, therapeutic tissue engineering products, human cell and tissue products, and certain combination products using such therapies. Examples include genetically-modified cellular … Continue reading →
Source: FDA Voice - Category: American Health Source Type: blogs